Profound Medical (PROF)
(Delayed Data from NSDQ)
$8.03 USD
0.00 (0.00%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $8.17 +0.14 (1.74%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/9/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.42 |
Last EPS Surprise | -50.00% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.17 |
Next Year | -1.04 |
EPS (TTM) | -1.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.40M | 2.73M | 11.03M | 29.85M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 2.70M | 2.90M | 11.80M | 45.00M |
Low Estimate | 2.20M | 2.60M | 10.50M | 17.50M |
Year ago Sales | 1.86M | 1.60M | 7.20M | 11.03M |
Year over Year Growth Est. | 29.03% | 70.81% | 53.15% | 170.75% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.30 | -1.17 | -1.04 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.37 | -0.34 | -0.96 | -0.96 |
High Estimate | -0.26 | -0.26 | -0.96 | -0.76 |
Low Estimate | -0.37 | -0.34 | -1.38 | -1.40 |
Year ago EPS | -0.32 | -0.35 | -1.35 | -1.17 |
Year over Year Growth Est. | 3.13% | 14.29% | 13.33% | 10.90% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.30 | -1.17 | -1.04 |
7 Days Ago | -0.31 | -0.30 | -1.17 | -1.04 |
30 Days Ago | -0.31 | -0.30 | -1.17 | -1.04 |
60 Days Ago | -0.30 | -0.30 | -1.04 | -0.87 |
90 Days Ago | -0.30 | -0.30 | -1.04 | -0.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.30 | -1.17 | -1.04 |
Zacks Consensus Estimate | -0.31 | -0.30 | -1.17 | -1.04 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -0.26 | -0.35 | -0.32 | NA |
Estimate | -0.28 | -0.32 | -0.31 | -0.38 | NA |
Difference | -0.14 | 0.06 | -0.04 | 0.06 | -0.02 |
Surprise | -50.00% | 18.75% | -12.90% | 15.79% | -7.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more